<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150919024080N19</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-06-24</date_registration>
      <primary_sponsor>Khoram-Abad University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Aromatherapy in CIPN and Fatigue</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Effectiveness of Aromatherapy-Massage with Classic Massage in Chemotherapy-Induced Neuropathic Pain and Fatigue in Cancer Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>75</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56034</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: First, patients are entered into the study consecutively, then patients who meet the inclusion criteria, by a person outside the research team, due to the observance of allocation concealment, based on a list of computer random numbers using stratified random block method in equal numbers in three groups of Aromatherapy-massage with main oil combination, classic massage with coconut oil or control with routine care. The strata in this study in order to match the groups is in terms of gender and the presence of neuropathic pain less than or equal to 3 and more than or equal to 4. Randomization stratas include: man with less than or equal to 3 pain score, man with more than or equal to 4 pain score, woman with less than or equal to 3 pain score, and woman with more than or equal to 4 pain score, Blinding description: Participants are informed about the three main groups and which group they are in, but their caregivers do not know which study group the patients are in. They are unaware of the composition and nature of the oils.; The primary caregiver who performs the intervention does not know what oil he is using and the intervention is performed using nasal clips; The research assistant who completes the questionnaires is independent of the intervention / massage procedure and does not know their group by coding the samples. Also, the statistician is not aware of the random assignment of groups when analyzing the data.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: Drug-induced polyneuropathy. Condition 2: Neoplastic (malignant) related fatigue.</hc_freetext>
      <i_freetext>Intervention 1: First Intervention group: In this group, Aromatherapy-Massage is performed using the main combination oil (lavender, chamomile, mint, coconut) prepared by Adonis Goldaroo Company. The main researcher teaches the family caregiver and the patient in a practical demonstration and video clip the steps of performing the procedure in a private and quiet space located in the oncology department in 30 minutes. The patient and the family caregiver practice Aromatherapy-Massage techniques several times in this practical session and after the researcher is sure of their understanding, the training ends; Then the researcher delivers a bottle containing 50 cc of 3% combined essential oil (for the Aromatherapy-Massage group) along with an pamphlet containing image (to explain and show the steps of the massage technique) and a schedule for the weekly massage to each participant. The family caregiver and the patient are asked to give aromatherapy massage three times a week for 30 minutes (with a break of 1 or 2 days between sessions) for 4 weeks in a room with a suitable temperature and privacy and during the hours when the patient is more comfortable and has the least severity of the side effects of chemotherapy (such as pain, nausea, fatigue),  in the following order:      1.The participants firstly lay on a bench, supine position, at the start of massage session. The PI (Primary Investigator) sit on a chair facing the patients' feet, which is at the PI's chest level during foot massage. The foot massage session begins by holding the right foot gently but firmly in both of the PI's hands. Effleurage is applied from toes to the ankle of foot, continued for all the fingers, and plantar muscles.                                 2.The PI uses her thumb to make superficial friction over the entire sole and all fingers of the foot. The sole is spread by the PI's fingers.        3.Then superficial friction is utilized for all fingers. Following the dorsum and all fingers massage, effleurage, and superficial friction is performed for the sole.                                                                                           4.Finally, the foot massage is finished with petrissage for the plantar muscles (10 min).                                                                                         5.Immediately after that, all massage techniques is utilized in a same manner for the left foot (10 min).                                                           6.After completion of foot massage, the patients are asked to sit on the bench. The PI hold the patient's hand gently in one of her hands.The hand massage begins with the right hand, and moving on to the left hand.   7.Effleurage is administered for the dorsum of the hand, and then moving on to all the fingers, and continued from the palm to the wrist.                 8.And then, the PI uses thumb and fingers to make superficial friction over the patient's entire palm, all fingers, and the outer surface of the hand, and finally petrissage for the thenar and hypothenar muscle groups. The palm is spread by the investigator's fingers.(5 min).                                           9.All massage techniques are used for the left hand (5 min).                        2 and 1 cc of oil will be used on each foot and hand, respectively. Intervention 2: Second Intervention group: For the second group or the classic massage group, instead of the combined oil, the classic massage is done only with coconut base oil prepared by Adonis Goldaroo company, in exactly the same way as described for the first group or Aromatherapy-Massage. In the second group, the amount of coconut oil and the time of the classic massage are similar to the first group. Intervention 3: Control group: For the third group or control group, no intervention will be performed except standard and routine care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amirhosein Hasanvand</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>In Front of Kahrizak Town, 5Km past Boroujerd Exit</address>
        <city>خرم‌آباد</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6817786337</zip>
        <telephone>+98 66 3321 3501</telephone>
        <email>amir.h1999@yahoo.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Gholami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>In Front of Kahrizak Town, 5Km past Boroujerd Exit</address>
        <city>Khorammabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6813833946</zip>
        <telephone>+98 912 509 1279</telephone>
        <email>gholami.m@lums.ac.ir</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The patient should be between 18 and 80 years old
Have at least one paraesthesia point (based on NRS)
More than 10,000 platelets per cubic millimeter of blood
No severe inflammatory lesions, itching or sores on the hands or feet
The patient must be in stage II or III cancer
Has received at least one session of chemotherapy and is scheduled to receive at least three more sessions within the next month
Existence of fatigue resistant to common treatments
If a specific cause for fatigue, such as anemia, insomnia, depression, or hypercalcemia, is identified, it should be treated first.
No history of peripheral neuropathy for any cause including diabetes mellitus, autoimmune disease, AIDS or previous chemotherapy
Patients with the infection are first treated with oral or intravenous antibiotics
No known mental illness
Ability to communicate and make telephone calls in Persian
After standardizing the fatigue score in the range of 0-100 people with a fatigue score above 30 and a pain score of 3 enter the study
Patient consent to participate in the study
No spread of metastasis to distant and vital organs such as brain and lymph nodes
Inclusion criteria for family caregiver: having a spouse or child relationship with the patient, experience of caring and following the patient for at least one month and willingness to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Deep vein thrombosis
Perform Aromatherapy-Massage for the past month
Dose reduction or discontinuation of medications
Allergy to lavender, chamomile and mint oils
Acute infections require oral or intravenous antibiotics or antiviral and antifungal drugs.
Drug therapy during the study to prevent or treat neuropathy
Existence of coagulation problems or taking anticoagulants
haemorrhage
Pregnancy
Soft tissue infection
Oncological emergencies (such as Tumor Lysis Syndrome)
Participate in other rehabilitation programs, meditation and hydrotherapy, etc. while studying
Exclusion criteria for family caregiver: change the role of family caregiver and transfer his/her role to other family members during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G62.0</hc_code>
      <hc_code>R53.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword>Neoplastic (malignant) related fatigue</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First Intervention group: In this group, Aromatherapy-Massage is performed using the main combination oil (lavender, chamomile, mint, coconut) prepared by Adonis Goldaroo Company. The main researcher teaches the family caregiver and the patient in a practical demonstration and video clip the steps of performing the procedure in a private and quiet space located in the oncology department in 30 minutes. The patient and the family caregiver practice Aromatherapy-Massage techniques several times in this practical session and after the researcher is sure of their understanding, the training ends; Then the researcher delivers a bottle containing 50 cc of 3% combined essential oil (for the Aromatherapy-Massage group) along with an pamphlet containing image (to explain and show the steps of the massage technique) and a schedule for the weekly massage to each participant. The family caregiver and the patient are asked to give aromatherapy massage three times a week for 30 minutes (with a break of 1 or 2 days between sessions) for 4 weeks in a room with a suitable temperature and privacy and during the hours when the patient is more comfortable and has the least severity of the side effects of chemotherapy (such as pain, nausea, fatigue),  in the following order:      1.The participants firstly lay on a bench, supine position, at the start of massage session. The PI (Primary Investigator) sit on a chair facing the patients' feet, which is at the PI's chest level during foot massage. The foot massage session begins by holding the right foot gently but firmly in both of the PI's hands. Effleurage is applied from toes to the ankle of foot, continued for all the fingers, and plantar muscles.                                 2.The PI uses her thumb to make superficial friction over the entire sole and all fingers of the foot. The sole is spread by the PI's fingers.        3.Then superficial friction is utilized for all fingers. Following the dorsum and all fingers massage, effleurage, and superficial friction is performed for the sole.                                                                                           4.Finally, the foot massage is finished with petrissage for the plantar muscles (10 min).                                                                                         5.Immediately after that, all massage techniques is utilized in a same manner for the left foot (10 min).                                                           6.After completion of foot massage, the patients are asked to sit on the bench. The PI hold the patient's hand gently in one of her hands.The hand massage begins with the right hand, and moving on to the left hand.   7.Effleurage is administered for the dorsum of the hand, and then moving on to all the fingers, and continued from the palm to the wrist.                 8.And then, the PI uses thumb and fingers to make superficial friction over the patient's entire palm, all fingers, and the outer surface of the hand, and finally petrissage for the thenar and hypothenar muscle groups. The palm is spread by the investigator's fingers.(5 min).                                           9.All massage techniques are used for the left hand (5 min).                        2 and 1 cc of oil will be used on each foot and hand, respectively.</i_keyword>
      <i_keyword>Second Intervention group: For the second group or the classic massage group, instead of the combined oil, the classic massage is done only with coconut base oil prepared by Adonis Goldaroo company, in exactly the same way as described for the first group or Aromatherapy-Massage. In the second group, the amount of coconut oil and the time of the classic massage are similar to the first group.</i_keyword>
      <i_keyword>Control group: For the third group or control group, no intervention will be performed except standard and routine care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Neropathic Pain. Timepoint: Before, 14 and 28 days after the start of the intervention. Method of measurement: DN4 questionnaire.</prim_outcome>
      <prim_outcome>Fatigue. Timepoint: Before, 14 and 28 days after the start of the intervention. Method of measurement: CFS questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khoram-Abad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-05-04</approval_date>
        <contact_name>Ethics Committee of Lorestan University of Medical Sciences</contact_name>
        <contact_address>In Front of Kahrizak Town, 5Km past Boroujerd Exit Khorammabad Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
